The intracellular activation of lamivudine (3TC) and determination of 2′-deoxycytidine-5′-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells

This publication has 42 references indexed in Scilit:

• Mutation in Hbv Rna–Dependent Dna Polymerase Confers Resistance to Lamivudine In Vivo
  Hepatology, 1996
• Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
  Hepatology, 1996
• Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis
  Liver International, 1995
• Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers
  Journal of Antimicrobial Chemotherapy, 1994
• Concurrent Use of Ganciclovir and Foscarnet to Treat Cytomegalovirus Infection in AIDS Patients
  The Journal of Infectious Diseases, 1993
• Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells
  Biochemical and Biophysical Research Communications, 1990
• Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo
  Antiviral Research, 1989
• Inhibition of duck hepatitis B virus replication by purine 2′,3′-dideoxynucleosides
  Biochemical and Biophysical Research Communications, 1988
• A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules
  Antiviral Research, 1987
• COMPARATIVE BIOCHEMISTRY OF DIHYDROFOLATE REDUCTASE
  Annals of the New York Academy of Sciences, 1971